The BPC-157/TB-500 blend, often called the "Wolverine Stack," combines two synthetic peptides designed to accelerate injury recovery
Their small, linear structures facilitate easier synthesis, high water solubility, and effective diffusion across biological barriers
Dosing is typically 200500 mcg/day based on anecdotal protocols
Another study in 1999 (Jelovac, et al) found the compound effective in healing stomach ulcers
The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion